Addendum: Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG)
Addendum-Yield-Microarray
Learn More
Phenylalanine hydroxylase deficiency diagnosis and management: A 2023 evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG)
Phenylalanine-hydroxylase-deficiency-EBG
Learn More
Management of individuals with heterozygous germline pathogenic variants in ATM: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG) (includes supplemental material)
Management-ATM
Learn More
Biomarker testing for lysosomal diseases: A technical standard of the American College of Medical Genetics and Genomics (ACMG)
Biomarker-testing-lysosomal-diseases
Learn More
The ACMG and ACMG Foundation Announce New 2025-2029 Strategic Plans
The ACMG and ACMG Foundation Announce New 2025-2029 Strategic Plans
Learn More
Casgevy (exagamglogene autotemcel) and Lyfgenia (lovotibeglogene autotemcel) for individuals 12 years and older with sickle cell disease (SCD) and recurrent vaso-occlusive crises (VOC): A therapeutics bulletin of the American College of Medical Genet
Casgevy-Lyfgenia-Sickle-Cell
Learn More
Points to consider for providing expert witness testimony for the specialty of medical genetics: A statement of the American College of Medical Genetics and Genomics (ACMG)
Expert-Witness-Testimony-Points
Learn More
Trofinetide approved for children and adults with Rett syndrome (RTT): A therapeutics bulletin of the American College of Medical Genetics and Genomics (ACMG)
Trofinetide-approved-for-children-and-adults-with-Rett-syndrome-RTT
Learn More
Myotonic dystrophy type 1 testing, 2024 revision: A technical standard of the American College of Medical Genetics and Genomics (ACMG)
Myotonic-dystrophy-2024-revision
Learn More
Consideration of disease penetrance in the selection of secondary findings gene-disease pairs: A policy statement of the American College of Medical Genetics and Genomics (ACMG)
Secondary-Findings-Penetrance-Policy
Learn More